Aurobindo Pharma's China Plant Fully Installed, Set for Operational Launch

7 Jun 2023 , 03:04 PM

Aurobindo Pharma has successfully completed the installation of its plant in China and is preparing to commission it in the first quarter of the next fiscal year. The company’s Chief Financial Officer, Santhanam Subramanian, confirmed the progress and stated that the China plant’s commissioning is scheduled for Q1 FY25.

The manufacturing of exhibit batches is underway, and Aurobindo Pharma plans to file around five products from the China plant. Initial dispatches from the plant will be focused on European markets, as obtaining approvals from Chinese regulators can be time-consuming.

Aurobindo Pharma has commissioning plans for three plants, including one in China. These strategic commissioning plans reflect Aurobindo Pharma’s commitment to expanding its manufacturing capabilities and strengthening its presence in key markets. The company’s progress in establishing the China plant highlights its global growth strategy and focus on delivering high-quality pharmaceutical products worldwide.

Aurobindo Pharma aims to leverage the new facilities to cater to increasing demand and further enhance its position in the pharmaceutical industry.

For feedback and suggestions, write to us at [e-mail]